A high-level U.S. nuclear industry delegation visited India this week to discuss reactor construction and investment opportunities [1].
This mission marks a pivotal shift in energy cooperation between the two nations. By addressing long-standing legal hurdles, the visit aims to catalyze the deployment of American nuclear technology to support India's growing energy demands.
The delegation, which includes representatives from the Nuclear Energy Institute (NEI) and the U.S.-India Strategic Partnership Forum (USISPF), traveled to New Delhi [1]. The visit took place from May 17-21, 2025 [2].
Central to these discussions is the SHANTI Act, which was enacted in 2025 [2]. The legislation is designed to ease liability concerns for foreign nuclear firms, a primary barrier that previously deterred U.S. companies from entering the Indian market [3].
U.S. delegates said that the SHANTI Act makes it possible for the industry to build nuclear reactors in India [3]. The framework allows commercial nuclear cooperation to proceed with reduced financial and legal risks for the providers of the technology [3].
Industry giants are now eyeing massive investment opportunities as a result of this legislative shift [1]. The cooperation prospects involve not only the construction of new plants, but also broader strategic partnerships in the nuclear sector [4].
This engagement follows years of diplomatic efforts to align the regulatory environments of both countries. The current mission serves as a practical application of the legal changes introduced by the 2025 act [2].
“The SHANTI Act eases liability concerns for foreign nuclear firms.”
The SHANTI Act removes the 'civil liability' deadlock that historically stalled U.S.-India nuclear deals. By shifting the risk profile for vendors, the U.S. can now export its reactor technology to one of the world's fastest-growing energy markets, potentially securing long-term strategic influence and commercial revenue in the Indo-Pacific region.
